HER2 status predicts for upfront AI benefit: a TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
- Creator: Bartlett, John M. S. , Ahmed, Ikhlaaq , Brookes, Cassandra L. , Forbes, John F. , Viale, Giuseppe , Cuzick, Jack , Dowsett, Mitchell , Rea, Daniel W. , Regan, Meredith M. , Sestak, Ivana , Mallon, Elizabeth A. , Dell'Orto, Patrizia , Thürlimann, Beat , Seynaeve, Caroline , Putter, Hein , Van de Velde, Cornelis J. H.
- Resource Type: journal article
- Date: 2017
Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives
- Creator: De Boer, Richard , Beith, Jane , Zdenkowski, Nicholas , Bell, Richard , Chirgwin, Jacquie , Chua, Sue , Colosimo, Maree , Francis, Prudence , Green, Michael , Pittman, Ken , White, Michelle , Wilcken, Nicholas
- Resource Type: journal article
- Date: 2014